In FeO NPs-DE-treated tumor-bearing mice, this nanocomplex had a higher potency for inhibiting ALDH1A1 activity by 74.2 ± 4.04% compared to Gem-treated tumor-bearing mice (2.59 ± 0.56%), as shown in Fig. 8f. The gene discussed is ALDH1A1; the disease is neoplasm.